Clincosm LogoSign in Get a demo

Gastric Cancer

Showing 51 - 75 of 1,371
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Healthy Trial in Hangzhou (No intervention)

Recruiting
  • Gastric Cancer
  • Healthy
  • No intervention
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Aug 7, 2023

Gastric Cancer, Signet Ring Cell Carcinoma Trial in Hangzhou (Without any intervention)

Active, not recruiting
  • Gastric Cancer
  • Signet Ring Cell Carcinoma
  • Without any intervention
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Aug 2, 2023

A Web-based Calculator Predicts Heterogeneous Frailty

Completed
  • Gastric Cancer
    • Nanjing, Jiangsu, China
    • +1 more
    Aug 1, 2023

    Gastric Cancer, Chemo Effect, Immune Checkpoint Inhibitor Trial in Shanghai (Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU)

    Recruiting
    • Gastric Cancer
    • +2 more
    • Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 1, 2023

    Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)

    Not yet recruiting
    • Gastric Cancer
    • Beijing, China
      Beijing Cancer Hospital
    Aug 7, 2023

    Gastric Cancer Trial in Singapore (SPECTRA IMDx™)

    Recruiting
    • Gastric Cancer
    • SPECTRA IMDx™
    • Singapore, Singapore
      National University Hospital
    Jul 26, 2023

    Gastric Cancer Trial in Shanghai (Serplulimab, Trastuzuma, Chemotherapy)

    Recruiting
    • Gastric Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 27, 2023

    Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma Trial (AVM0703, Hydrocortisone, Proton pump inhibitor)

    Available
    • Glioblastoma
    • +13 more
    • (no location specified)
    Jul 26, 2023

    High-risk Population for Gastric Cancer in Latin America: The

    Completed
    • Gastric Cancer
    • +3 more
      • Santiago, Metropolitana, Chile
      • +1 more
      Jul 27, 2023

      Gallstone, Gastric Cancer Trial in Lanzhou, Wuwei (Distal gastrectomy and radical resection, Total gastrectomy and radical

      Not yet recruiting
      • Gallstone
      • Gastric Cancer
      • Distal gastrectomy and radical resection
      • Total gastrectomy and radical resection
      • Lanzhou, Gansu, China
      • +1 more
      Jul 27, 2023

      Gastric Cancer Trial in Seoul (Arm I : Experimental (Prucalopride succinate group), Arm II : Control (Mosapride citrate group))

      Completed
      • Gastric Cancer
      • Arm I : Experimental (Prucalopride succinate group)
      • Arm II : Control (Mosapride citrate group)
      • Seoul, Korea, Republic of
        GangnamSeverance Hospital
      Jul 21, 2023

      Gastric Cancer, Nutrition Related Cancer, Sarcopenia Trial (Exercise Intervention, Nutrition Intervention)

      Not yet recruiting
      • Gastric Cancer
      • +2 more
      • Exercise Intervention
      • Nutrition Intervention
      • (no location specified)
      Jul 17, 2023

      Gastric Cancer, Precancerous Lesion of Digestive Tract, Extrachromosomal DNA Trial (gastroscopy)

      Not yet recruiting
      • Gastric Cancer
      • +2 more
      • gastroscopy
      • (no location specified)
      Jul 14, 2023

      Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)

      Recruiting
      • Breast Cancer
      • +5 more
      • 89Zr-DFO*-trastuzumab PET scan
      • Amsterdam, Noord-Holland, Netherlands
        AmsterdamUMC
      Jul 12, 2023

      Gastric Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting Claudin18.2)

      Recruiting
      • Gastric Cancer
      • Chimeric antigen receptor T cell preparation targeting Claudin18.2
      • Qingdao, Shandong, China
        The Affiliated Hospital of Qingdao University
      Jul 11, 2023

      Gastric Cancer Trial (S-1, Oxaliplatin, Cadonilimab)

      Not yet recruiting
      • Gastric Cancer
      • S-1, Oxaliplatin, Cadonilimab
      • (no location specified)
      Jul 10, 2023

      Genomic and Dietary Aspects in Gastric Cancer Risk

      Not yet recruiting
      • Gastric Cancer
        • Roma, Italia, Italy
          Dipartimento Universitario di Scienze della Vita e Sanità Pubbli
        Jun 28, 2023

        Gastric Cancer, Pancreatic Cancer Trial (LM302+Toripalimab)

        Not yet recruiting
        • Gastric Cancer
        • Pancreatic Cancer
        • (no location specified)
        Jun 28, 2023

        Gastric Cancer Trial (Disitamab Vedotin combined with Sintilimab)

        Not yet recruiting
        • Gastric Cancer
        • Disitamab Vedotin combined with Sintilimab
        • (no location specified)
        Jul 2, 2023

        ESD for the Treatment of Superficial Gastric Neoplasms

        Recruiting
        • Gastric Cancer
        • Endoscopic Submucosal Dissection
        • Rome, Italy
          Digestive Endoscopy Unit, Fondazione Policlinico Universitario A
        Jul 3, 2023

        System in Early Detection of Gastric Cancer in France. Cancer in

        Recruiting
        • Gastric Cancer
        • Evaluation of the proportion of gastric neoplastic lesions detected by a computer-aided diagnosis system (CADx) compared with experienced endoscopists.
        • Lyon, France
          Hôpital Edouard Herriot
        Jun 23, 2023

        Gastric and Pancreatic Cancers in Latin America

        Not yet recruiting
        • Gastric Cancer
        • +2 more
        • Observational study
        • (no location specified)
        Jun 20, 2023

        Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

        Recruiting
        • Cancer
        • +11 more
        • San Antonio, Texas
          South Texas Accelerated Research Therapeutics, LLC
        Jun 21, 2023

        Gastric Cancer Trial in China (Experimental dose: modified XELOX + sintilimab, Standard dose: standard XELOX + sintilimab)

        Recruiting
        • Gastric Cancer
        • Experimental dose: modified XELOX + sintilimab
        • Standard dose: standard XELOX + sintilimab
        • Guangzhou, Guangdong, China
        • +9 more
        Jun 23, 2023

        Gastric Cancer Trial (Envolimab, Fuquinitinib, Oxaliplatin)

        Not yet recruiting
        • Gastric Cancer
        • (no location specified)
        Jun 13, 2023